Interferon regulatory factor 8 protects against cerebral ischaemic-reperfusion injury

Journal of Neurochemistry

Volumn 129, Issue 6, 2014, Pages 988-1001

  Xiang, Mei ^a,b   Wang, Lang ^a,b   Guo, Sen ^a,b   Lu, Yan Yun ^a,b   Lei, Hao ^c   Jiang, Ding Sheng ^a,b   Zhang, Yan ^a,b   Liu, Yi ^b   Zhou, Yan ^b   Zhang, Xiao Dong ^b   Li, Hongliang ^a,b  

^a RENMIN HOSPITAL OF WUHAN UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

^c INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

Author keywords

apoptosis; inflammation; IRF8; ischaemia; oxidative stress; stroke

Indexed keywords

GLUCOSE; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; OXYGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CORTEX; BRAIN INFARCTION SIZE; BRAIN NERVE CELL; BRAIN TISSUE; CELL HYPOXIA; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; IN VITRO STUDY; INFLAMMATION; KNOCKOUT MOUSE; MALE; MOUSE; NERVE CELL NECROSIS; NEUROMODULATION; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REPERFUSION INJURY; TRANSGENIC MOUSE; TRANSIENT ISCHEMIC ATTACK; WILD TYPE;

MUS; MUS MUSCULUS;

APOPTOSIS; INFLAMMATION; IRF8; ISCHAEMIA; OXIDATIVE STRESS; STROKE;

ADENOVIRIDAE; ANIMALS; BLOTTING, WESTERN; BRAIN ISCHEMIA; CELLS, CULTURED; CEREBRAL INFARCTION; FLUORESCEINS; FLUORESCENT ANTIBODY TECHNIQUE; FLUORESCENT DYES; GENETIC VECTORS; IN SITU NICK-END LABELING; INTERFERON REGULATORY FACTORS; L-LACTATE DEHYDROGENASE; MAGNETIC RESONANCE IMAGING; MICE; MICE, KNOCKOUT; NERVOUS SYSTEM DISEASES; NEURONS; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; RATS; REPERFUSION INJURY; STROKE;

EID: 84902375462     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/jnc.12682     Document Type: Article

References (48)

1. Allen C. L., and, Bayraktutan U., (2009) Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int. J. Stroke 4, 461-470.
2. Baldwin K., Orr S., Briand M., Piazza C., Veydt A., and, McCoy S., (2010) Acute ischemic stroke update. Pharmacotherapy 30, 493-514.
3. Bronner L. L., Kanter D. S., and, Manson J. E., (1995) Primary prevention of stroke. N. Engl. J. Med. 333, 1392-1400.
4. Broughton B. R., Reutens D. C., and, Sobey C. G., (2009) Apoptotic mechanisms after cerebral ischemia. Stroke 40, e331-e339.
5. Brouns R., and, De Deyn P. P., (2009) The complexity of neurobiological processes in acute ischemic stroke. Clin. Neurol. Neurosurg. 111, 483-495.
6. Burchert A., Cai D., Hofbauer L. C., et al,. (2004) Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR/ABL and down-regulates bcl-2. Blood 103, 3480-3489.
7. Campbell S. J., Wilcockson D. C., Butchart A. G., Perry V. H., and, Anthony D. C., (2002) Altered chemokine expression in the spinal cord and brain contributes to differential interleukin-1beta-induced neutrophil recruitment. J. Neurochem. 83, 432-441.
8. Candelario-Jalil E., (2009) Injury and repair mechanisms in ischemic stroke: considerations for the development of novel neurotherapeutics. Curr. Opin. Investig. Drugs 10, 644-654.
9. Chrabot B. S., Kariuki S. N., Zervou M. I., Feng X., Arrington J., Jolly M., Boumpas D. T., Reder A. T., Goulielmos G. N., and, Niewold T. B., (2013) Genetic variation near IRF8 is associated with serologic and cytokine profiles in systemic lupus erythematosus and multiple sclerosis. Genes Immun. 14, 471-478.
10. De Jager P. L., Jia X., Wang J., et al,. (2009) Meta-Analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci. Nat. Genet. 41, 776-782.
11. Doyle K. P., Simon R. P., and, Stenzel-Poore M. P., (2008) Mechanisms of ischemic brain damage. Neuropharmacology 55, 310-318.
12. Dragatsis I., and, Zeitlin S., (2000) CaMKIIalpha-Cre transgene expression and recombination patterns in the mouse brain. Genesis 26, 133-135.
13. Driggers P. H., Ennist D. L., Gleason S. L., Mak W. H., Marks M. S., Levi B. Z., Flanagan J. R., Appella E., and, Ozato K., (1990) An interferon gamma-regulated protein that binds the interferon-inducible enhancer element of major histocompatibility complex class I genes. Proc. Natl Acad. Sci. USA 87, 3743-3747.
14. Holtschke T., Löhler J., Kanno Y., et al,. (1996) Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell 87, 307-317.
15. Horiuchi M., Wakayama K., Itoh A., Kawai K., Pleasure D., Ozato K., and, Itoh T., (2012) Interferon regulatory factor 8/interferon consensus sequence binding protein is a critical transcription factor for the physiological phenotype of microglia. J. Neuroinflammation 9, 227.
16. Hu X., Yang D., Zimmerman M., et al,. (2011) IRF8 regulates acid ceramidase expression to mediate apoptosis and suppresses myelogeneous leukemia. Cancer Res. 71, 2882-2891.
17. Imai H., Masayasu H., Dewar D., Graham D. I., and, Macrae I. M., (2001) Ebselen protects both gray and white matter in a rodent model of focal cerebral ischemia. Stroke 32, 2149-2154.
18. Jiang D. S., Bian Z. Y., Zhang Y., et al,. (2013) Role of interferon regulatory factor 4 in the regulation of pathological cardiac hypertrophy. Hypertension 61, 1193-1202.
19. Kawai H., Deguchi S., Deguchi K., et al,. (2011) Synergistic benefit of combined amlodipine plus atorvastatin on neuronal damage after stroke in Zucker metabolic rat. Brain Res. 1368, 317-323.
20. Kelly P. T., and, Vernon P., (1985) Changes in the subcellular distribution of calmodulin-kinase II during brain development. Brain Res. 350, 211-224.
21. Kurotaki D., Osato N., Nishiyama A., et al,. (2013) Essential role of the IRF8-KLF4 transcription factor cascade in murine monocyte differentiation. Blood 121, 1839-1849.
22. Kweon M. H., Adhami V. M., Lee J. S., and, Mukhtar H., (2006) Constitutive overexpression of Nrf2-dependent heme oxygenase-1 in A549 cells contributes to resistance to apoptosis induced by epigallocatechin 3-gallate. J. Biol. Chem. 281, 33761-33772.
23. Lakhan S. E., Kirchgessner A., and, Hofer M., (2009) Inflammatory mechanisms in ischemic stroke: therapeutic approaches. J. Transl. Med. 7, 97.
24. Lu J., Bian Z. Y., Zhang R., et al,. (2013a) Interferon regulatory factor 3 is a negative regulator of pathological cardiac hypertrophy. Basic Res. Cardiol. 108, 326.
25. Lu Y. Y., Li Z. Z., Jiang D. S., et al,. (2013b) TRAF1 is a critical regulator of cerebral ischaemia-reperfusion injury and neuronal death. Nat. Commun. 4, 2852.
26. Marecki S., Atchison M. L., and, Fenton M. J., (1999) Differential expression and distinct functions of IFN regulatory factor 4 and IFN consensus sequence binding protein in macrophages. J. Immunol. 163, 2713-2722.
27. Masuda T., Tsuda M., Yoshinaga R., Tozaki-Saitoh H., Ozato K., Tamura T., and, Inoue K., (2012) IRF8 is a critical transcription factor for transforming microglia into a reactive phenotype. Cell Rep. 1, 334-340.
28. Murray V., Norrving B., Sandercock P. A., Terent A., Wardlaw J. M., and, Wester P., (2010) The molecular basis of thrombolysis and its clinical application in stroke. J. Intern. Med. 267, 191-208.
29. Park T. J., Kim H. J., Kim J. H., Bae J. S., Cheong H. S., Park B. L., and, Shin H. D., (2013) Associations of CD6, TNFRSF1A and IRF8 polymorphisms with risk of inflammatory demyelinating diseases. Neuropathol. Appl. Neurobiol. 39, 519-530.
30. Paun A., and, Pitha P. M., (2007) The IRF family, revisited. Biochimie 89, 744-753.
31. Schnell L., Fearn S., Klassen H., Schwab M. E., and, Perry V. H., (1999) Acute inflammatory responses to mechanical lesions in the CNS: differences between brain and spinal cord. Eur. J. Neurosci. 11, 3648-3658.
32. Sugawara T., Fujimura M., Noshita N., Kim G. W., Saito A., Hayashi T., Narasimhan P., Maier C. M., and, Chan P. H., (2004) Neuronal death/survival signaling pathways in cerebral ischemia. NeuroRx 1, 17-25.
33. Tailor P., Tamura T., and, Ozato K., (2006) IRF family proteins and type I interferon induction in dendritic cells. Cell Res. 16, 134-140.
34. Tamura T., and, Ozato K., (2002) ICSBP/IRF-8: its regulatory roles in the development of myeloid cells. J. Interferon Cytokine Res. 22, 145-152.
35. Tamura T., Yanai H., Savitsky D., and, Taniguchi T., (2008) The IRF family transcription factors in immunity and oncogenesis. Annu. Rev. Immunol. 26, 535-584.
36. Tu J. V., (2010) Reducing the global burden of stroke: INTERSTROKE. Lancet 376, 74-75.
37. Wang B., Cao W., Biswal S., and, Doré S., (2011) Carbon monoxide-Activated Nrf2 pathway leads to protection against permanent focal cerebral ischemia. Stroke 42, 2605-2610.
38. Wang L., Lu Y., Deng S., Zhang Y., Yang L., Guan Y., Matozaki T., Ohnishi H., Jiang H., and, Li H., (2012a) SHPS-1 deficiency induces robust neuroprotection against experimental stroke by attenuating oxidative stress. J. Neurochem. 122, 834-843.
39. Wang L., Deng S., Lu Y., Zhang Y., Yang L., Guan Y., Jiang H., and, Li H., (2012b) Increased inflammation and brain injury after transient focal cerebral ischemia in activating transcription factor 3 knockout mice. Neuroscience 220, 100-108.
40. Wang L., Lu Y., Guan H., et al,. (2013a) Tumor necrosis factor receptor-Associated factor 5 is an essential mediator of ischemic brain infarction. J. Neurochem. 126, 400-414.
41. Wang L., Lu Y., Zhang X., et al,. (2013b) Mindin is a critical mediator of ischemic brain injury in an experimental stroke model. Exp. Neurol. 247, 506-516.
42. Wang X. A., Zhang R., Jiang D., et al,. (2013c) Interferon regulatory factor 9 protects against hepatic insulin resistance and steatosis in male mice. Hepatology 58, 603-616.
43. Weisz A., Marx P., Sharf R., Appella E., Driggers P. H., Ozato K., and, Levi B. Z., (1992) Human interferon consensus sequence binding protein is a negative regulator of enhancer elements common to interferon-inducible genes. J. Biol. Chem. 267, 25589-25596.
44. Xia C. F., Smith R. S., Jr, Shen B., Yang Z. R., Borlongan C. V., Chao L., and, Chao J., (2006) Postischemic brain injury is exacerbated in mice lacking the kinin B2 receptor. Hypertension 47, 752-761.
45. Yang D., Thangaraju M., Greeneltch K., Browning D. D., Schoenlein P. V., Tamura T., Ozato K., Ganapathy V., Abrams S. I., and, Liu K., (2007a) Repression of IFN regulatory factor 8 by DNA methylation is a molecular determinant of apoptotic resistance and metastatic phenotype in metastatic tumor cells. Cancer Res. 67, 3301-3309.
46. Yang D., Thangaraju M., Browning D. D., Dong Z., Korchin B., Lev D. C., Ganapathy V., and, Liu K., (2007b) IFN regulatory factor 8 mediates apoptosis in nonhemopoietic tumor cells via regulation of Fas expression. J. Immunol. 179, 4775-4782.
47. Yang D., Wang S., Brooks C., et al,. (2009) IFN regulatory factor 8 sensitizes soft tissue sarcoma cells to death receptor-initiated apoptosis via repression of FLICE-like protein expression. Cancer Res. 69, 1080-1088.
48. Yi J. H., Park S. W., Kapadia R., and, Vemuganti R., (2007) Role of transcription factors in mediating post-ischemic cerebral inflammation and brain damage. Neurochem. Int. 50, 1014-1027.